Cargando…
New developments in acne treatment: role of combination adapalene–benzoylperoxide
The fixed-dose combination adapalene 0.1%/benzoylperoxide 2.5% (A/BPO) was introduced as an acne vulgaris therapeutic in 2007. It combines anti-inflammatory, keratolytic, comedolytic, and antibacterial properties. Thus, it addresses several pathophysiological factors involved in the pathophysiology...
Autores principales: | Kim, Su Youn, Ochsendorf, Falk R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055040/ https://www.ncbi.nlm.nih.gov/pubmed/27757036 http://dx.doi.org/10.2147/TCRM.S94062 |
Ejemplares similares
-
A review of the use of adapalene for the treatment of acne vulgaris
por: Piskin, Suleyman, et al.
Publicado: (2007) -
Development of Adapalene Loaded Liposome Based Gel for Acne
por: Arooj, Asma, et al.
Publicado: (2023) -
Electrostatically optimized adapalene-loaded emulsion for the treatment of acne vulgaris
por: Ji, Yun Bae, et al.
Publicado: (2022) -
Adapalene 0.3% Gel Shows Efficacy for the Treatment of Atrophic Acne Scars
por: Loss, Manisha J., et al.
Publicado: (2018) -
Effects of Adapalene-Benzoyl Peroxide Combination Gel in Treatment or Maintenance Therapy of Moderate or Severe Acne Vulgaris: A Meta-Analysis
por: Zhou, Rongying, et al.
Publicado: (2014)